Use of evoked potentials in predicting disease progression

Takeaway

  • Using an evoked potentials (EP) score comprised of multiple types of EP in people with clinically isolated syndrome (CIS) may improve prediction of disease progression.

Why this matters ?

  • In many multiple sclerosis (MS) cases, CIS precedes diagnosis of MS, and the ability to determine disease progression of CIS with a biomarker would be clinically beneficial.

  • Brainstem lesions may be a predictor of disability in people with CIS, and measuring EP to create an EP score may be a viable way to evaluate those brainstem lesions.